Initial share issuance to B. Riley Principal Capital II
Company: Core Scientific
The claim, verbatim
573,381 shares of common stock were issued to B. Riley Principal Capital II on July 20, 2022 as consideration for its commitment to purchase shares
Source (primary)
Core Scientific 424B3 filed 2022-10-12 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “Concurrently with our execution of the Purchase Agreement on July 20, 2022, we issued 573,381 shares of Common Stock, which are part of the CEF Shares included in the Prospectus, to B. Riley Principal Capital II as consideration for its irrevocable commitment”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states the 573,381 shares were issued concurrently with the July 20, 2022 agreement as consideration for the commitment.
Confirmed in the source:
- 573,381 shares of common stock were issued to B. Riley Principal Capital II on July 20, 2022
- The shares were consideration for its irrevocable commitment to purchase shares
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522260971/d409553d424b3.htm) in full (14,683 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-12
Quote: “Concurrently with our execution of the Purchase Agreement on July 20, 2022, we issued 573,381 shares of Common Stock, which are part of the CEF Shares included in the Prospectus, to B. Riley Principal Capital II as consideration for its irrevocable commitment”